Bicocca Open Archive

Logo unimib boa
GERUSSI, ALESSIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.200
EU - Europa 7.227
AS - Asia 6.595
SA - Sud America 976
Continente sconosciuto - Info sul continente non disponibili 547
AF - Africa 173
OC - Oceania 8
Totale 24.726
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.748
SE - Svezia 2.387
SG - Singapore 2.137
IT - Italia 1.921
VN - Vietnam 1.418
CN - Cina 1.100
HK - Hong Kong 880
RU - Federazione Russa 734
BR - Brasile 720
DE - Germania 701
IE - Irlanda 344
CA - Canada 335
GB - Regno Unito 283
FR - Francia 208
IN - India 204
BD - Bangladesh 160
KR - Corea 129
FI - Finlandia 113
ID - Indonesia 103
AR - Argentina 96
NL - Olanda 95
IQ - Iraq 68
AT - Austria 66
ES - Italia 65
ZA - Sudafrica 64
PL - Polonia 59
CH - Svizzera 56
TR - Turchia 56
MX - Messico 50
SA - Arabia Saudita 47
UA - Ucraina 41
MY - Malesia 40
PH - Filippine 39
EC - Ecuador 37
CO - Colombia 33
PK - Pakistan 33
JP - Giappone 28
VE - Venezuela 28
DK - Danimarca 27
BE - Belgio 26
LT - Lituania 24
UZ - Uzbekistan 24
IL - Israele 21
JM - Giamaica 20
MA - Marocco 19
CL - Cile 15
KE - Kenya 15
CZ - Repubblica Ceca 14
TN - Tunisia 14
CR - Costa Rica 13
PY - Paraguay 13
BO - Bolivia 12
EG - Egitto 12
JO - Giordania 12
AZ - Azerbaigian 11
ET - Etiopia 10
IR - Iran 10
KZ - Kazakistan 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
SK - Slovacchia (Repubblica Slovacca) 9
UY - Uruguay 9
AU - Australia 7
GR - Grecia 7
PE - Perù 7
PT - Portogallo 7
RS - Serbia 7
TW - Taiwan 7
NP - Nepal 6
PA - Panama 6
TT - Trinidad e Tobago 6
HU - Ungheria 5
MM - Myanmar 5
RO - Romania 5
SY - Repubblica araba siriana 5
AO - Angola 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
MD - Moldavia 4
PS - Palestinian Territory 4
QA - Qatar 4
TH - Thailandia 4
AL - Albania 3
BG - Bulgaria 3
CG - Congo 3
GE - Georgia 3
GT - Guatemala 3
GY - Guiana 3
HN - Honduras 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
MU - Mauritius 3
NO - Norvegia 3
SC - Seychelles 3
SV - El Salvador 3
BY - Bielorussia 2
GD - Grenada 2
GH - Ghana 2
KH - Cambogia 2
Totale 24.142
Salva come PNG Salva come JPEG
Città #
Stockholm 1.879
Singapore 1.293
Ann Arbor 1.272
Hong Kong 848
Ashburn 833
San Jose 723
Milan 689
Frankfurt am Main 522
Ho Chi Minh City 432
Hanoi 362
Fairfield 361
Dublin 328
Chandler 293
Dallas 285
Wilmington 271
Chicago 262
Toronto 258
Los Angeles 253
New York 247
Santa Clara 241
Hefei 221
Council Bluffs 214
Boardman 183
Woodbridge 167
The Dalles 153
Seattle 151
Houston 147
Rome 140
Beijing 132
Seoul 123
Cambridge 119
London 117
Princeton 103
Lauterbourg 102
Columbus 97
Buffalo 82
Jakarta 78
Shanghai 75
Helsinki 74
São Paulo 73
Moscow 70
Dearborn 66
Munich 62
Orem 49
Turin 48
Zurich 48
Altamura 46
Lawrence 46
Haiphong 41
Warsaw 41
Da Nang 40
Monza 38
Biên Hòa 35
Florence 33
Johannesburg 33
San Diego 31
Vienna 31
Denver 30
Ha Long 30
Montreal 29
Nuremberg 29
Rio de Janeiro 28
Atlanta 26
Brooklyn 26
Hải Dương 26
Naples 26
Pune 25
Figino 24
Tokyo 24
Boston 23
Can Tho 23
Jacksonville 23
Phoenix 23
Quận Bình Thạnh 23
Baghdad 22
New Delhi 22
Turku 22
Brussels 21
Mumbai 21
Ninh Bình 21
Amsterdam 20
Bologna 20
Guangzhou 20
Riyadh 20
Salt Lake City 20
Chennai 19
Tashkent 19
Belo Horizonte 18
Bari 17
Lappeenranta 17
Bắc Ninh 16
Jeddah 16
Penang 16
Poplar 16
Tampa 16
Dhaka 15
Genoa 15
Quito 15
Vũng Tàu 15
Washington 15
Totale 15.873
Salva come PNG Salva come JPEG
Nome #
Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial 1.993
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 610
Gamma-Glutamyl Transferase in Patients With Primary Biliary Cholangitis 458
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 420
A second update on mapping the human genetic architecture of COVID-19 393
Mapping the human genetic architecture of COVID-19 373
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 354
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 351
Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms 350
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 347
Risk stratification in primary sclerosing cholangitis 340
Precision medicine in primary biliary cholangitis 338
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 337
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 329
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 326
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 307
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 306
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 303
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 301
New Therapeutic Targets in Autoimmune Cholangiopathies 295
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 294
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 293
Immune-mediated drug-induced liver injury: Immunogenetics and experimental models 290
Better end points needed in primary sclerosing cholangitis trials 285
Artificial Intelligence and liver: Opportunities and barriers 277
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 269
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis 266
Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis 263
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 260
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 258
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 257
DISSECTING THE GENETIC ARCHITECTURE OF AUTOIMMUNITY: A SPOTLIGHT ON PRIMARY BILIARY CHOLANGITIS 255
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 254
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 253
Artificial intelligence for precision medicine in autoimmune liver disease 250
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe 247
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 243
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 243
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 243
Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers 242
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 240
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 237
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 235
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 231
Stratified analyses refine association between TLR7 rare variants and severe COVID-19 229
A National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis 229
Novel insights in primary biliary cholangitis (PBC) epidemiology using administrative records 228
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 228
X marks the spot in autoimmunity 221
Established cirrhosis at the time of diagnosis predicts adverse outcome in autoimmune hepatitis: A retrospective cohort study 221
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 219
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 215
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities 215
The phenotypic landscape of primary biliary cholangitis and autoimmune hepatitis variants 213
Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis 209
The immunobiology of female predominance in primary biliary cholangitis 208
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 207
Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581, (S0168827821003342), (10.1016/j.jhep.2021.04.055)] 206
Open challenges in the management of autoimmune hepatitis 199
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis 196
The Role of Epigenetics in Primary Biliary Cholangitis 195
Cost of illness of Primary Biliary Cholangitis - a population-based study 192
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 187
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 184
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease 183
Automating liver biopsy segmentation with a robust, open-source tool for pathology research: the HOTSPoT model 178
The application of artificial intelligence in hepatology: A systematic review 173
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group 173
Gender differences in liver disease and the drug-dose gender gap 170
The role of ethnicity in autoimmune hepatitis 167
Normalization of serum immunoglobulin G levels is associated with improved transplant-free survival in patients with autoimmune hepatitis 165
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 162
MEDTEC students against coronavirus: Investigating the role of hemostatic genes in the predisposition to COVID-19 severity 160
Bacterascites confers poor patient prognosis beyond MELD prediction 156
Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All 155
GWAS and autoimmunity: What have we learned and what next 153
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 152
The prognosis following bacterascites is as poor as spontaneous bacterial peritonitis 152
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis 144
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 142
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on alkaline phosphatase 136
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on the alkaline phosphatase 133
Elevated baseline igg is a risk factor for on-treatment flares of autoimmune hepatitis in patients in biochemical remission 133
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 126
Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 125
ANTITUMOR ACTIVITY OF A NOVEL FGFR INHIBITOR IN INTRAHEPATIC CHOLANGIOCARCINOMA 123
Genetics of Autoimmune Liver Diseases 119
Primary Sclerosing Cholangitis 118
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 116
Genetics of Primary Biliary Cholangitis 115
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 111
The genetic architecture of primary biliary cholangitis 107
Black Ethnicity Affects the Clinical Presentation and Outcome in Autoimmune Hepatitis 105
Diagnosing Autoimmune Hepatitis: Histological Correlations and Emerging Technologies 101
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 100
Editorial: liver transplantation for primary biliary cholangitis–the need for timely and more effective treatments 100
Steroid-loaded Avidin-Nucleic-Acid-Nano-Assemblies reduce hepatic fibrosis modulating Kupffer cells in primary biliary cholangitis 99
Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis 92
EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) 87
Kupffer cell autophagy emerges as a central regulator of immune dysregulation in primary biliary cholangitis 86
Totale 24.034
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.679
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022944 0 104 160 108 79 61 43 69 48 25 85 162
2022/20231.850 172 440 148 141 236 245 86 90 112 64 70 46
2023/20241.644 49 59 75 161 187 328 207 37 76 172 40 253
2024/20253.885 254 400 218 187 325 197 247 209 426 532 361 529
2025/202612.635 1.536 827 807 1.113 954 499 1.422 519 797 2.715 590 856
2026/2027969 406 563 0 0 0 0 0 0 0 0 0 0
Totale 24.726